Drugs / Autologous Adipose-Derived Adult Stromal Vascular Fraction (SVF) cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03762967 | Mar 2018 → Dec 2020 | azoospermia, oligospermia | State-Financed Health Facility "Samara Regional Medical Center Dinasty" | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Adipose-Derived Adult Stromal Vascular Fraction (SVF) cells | “The purpose of this study is to assess the ability of Autologous Adipose-Derived Adult Stromal Vascular Fraction (SVF) cells to stimulate Sertoli and spermatogonia cells and...” NCT03762967 ↗ |
| Known as | SVF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03762967 ↗ |
| Action | Activate | “to stimulate Sertoli and spermatogonia cells” NCT03762967 ↗ |
| Modality | Cell therapy | “Autologous Adipose-Derived Adult Stromal Vascular Fraction (SVF) cells” NCT03762967 ↗ |
| Route | Other | “introduction into testis Interstitium” NCT03762967 ↗ |